Cybin to Buy Clinical Trial From Entheon Biomedical to Advance Development of CYB004
Cybin to Buy Clinical Trial From Entheon Biomedical to Advance Development of CYB004
Cybin将从Entheon Biomedical购买临床试验以推进CyB004的开发
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。